| Device Classification Name |
Thymidine Kinase Activity
|
| 510(k) Number |
K202852 |
| Device Name |
DiviTum TKa |
| Applicant |
| Biovica International AB |
| Dag Hammarskjölds Väg 54b |
|
Uppsala,
SE
75237
|
|
| Applicant Contact |
Joakim Arwidson |
| Correspondent |
| Biovica International AB |
| Dag Hammarskjölds Väg 54b |
|
Uppsala,
SE
75237
|
|
| Correspondent Contact |
Joakim Arwidson |
| Regulation Number | 866.6010 |
| Classification Product Code |
|
| Date Received | 09/28/2020 |
| Decision Date | 07/29/2022 |
| Decision |
Substantially Equivalent
(SESE) |
| Regulation Medical Specialty |
Immunology
|
| 510k Review Panel |
Immunology
|
| Summary |
Summary
|
| FDA Review |
Decision Summary
|
| Type |
Traditional
|
| Reviewed by Third Party |
No
|
| Combination Product |
No
|
Predetermined Change Control Plan Authorized |
No
|
|
|